BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6187316)

  • 21. A neutralizing monoclonal antibody against poliovirus and its reaction with related antigens.
    Icenogle J; Gilbert SF; Grieves J; Anderegg J; Rueckert R
    Virology; 1981 Nov; 115(1):211-5. PubMed ID: 6270899
    [No Abstract]   [Full Text] [Related]  

  • 22. A competition immunoprecipitation assay of unlabeled poliovirus antigens.
    Rombaut B; Jore J; Boeyé A
    J Virol Methods; 1994 Jun; 48(1):73-9. PubMed ID: 7962262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping of type 1 poliovirus neutralization epitopes.
    Blondel B; Crainic R; Dufraisse G; Candréa A; Horaud F
    Dev Biol Stand; 1985; 60():337-42. PubMed ID: 2412917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of monoclonal antibodies in virology].
    Lashkevich VA
    Vopr Virusol; 1983; 28(6):648-54. PubMed ID: 6322450
    [No Abstract]   [Full Text] [Related]  

  • 25. Detection by monoclonal antibodies of an antigenic determinant critical for poliovirus neutralization present on VP1 and on heat-inactivated virions.
    Blondel B; Akacem O; Crainic R; Couillin P; Horodniceanu F
    Virology; 1983 Apr; 126(2):707-10. PubMed ID: 6190311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibodies against a plant virus.
    Dietzgen RG; Sander E
    Arch Virol; 1982; 74(2-3):197-204. PubMed ID: 6187313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies to poliovirus detected by immunoradiometric assay with a monoclonal antibody.
    Spitz M; Fossati CA; Schild GC; Spitz L; Brasher M
    J Virol Methods; 1982 Oct; 5(2):101-11. PubMed ID: 6296172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poliovirus neutralization and the percentage law. Brief report.
    Brioen P; Boeyé A
    Arch Virol; 1985; 83(1-2):105-11. PubMed ID: 2982345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal antibodies specific for the virion polypeptide, p27, of avian retroviruses.
    Parsons SJ; Wilson LD; Ely CM; Parsons JT; Benjamin DC
    Hybridoma; 1984; 3(1):25-31. PubMed ID: 6205983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro stimulation of presensitized mouse spleen cells with poliovirus type 1, Mahoney, and enhancement of poliovirus-specific hybridomas.
    Wiegers KJ; Uhlig H; Dernick R
    J Gen Virol; 1986 Sep; 67 ( Pt 9)():2053-7. PubMed ID: 3018136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of monoclonal antibodies for the identification of the antigenic site for poliovirus neutralization.
    Minor PD; Schild GC; Evans D; Ferguson M; Almond J
    Dev Biol Stand; 1984; 57():171-5. PubMed ID: 6084608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of antigenic determinants by polyclonal and hybridoma antibodies induced during the course of infection by vaccinia virus.
    Wilton S; Gordon J; Dales S
    Virology; 1986 Jan; 148(1):84-96. PubMed ID: 2417414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigenic sites of poliovirus type 3 eliciting IgA monoclonal antibodies in orally immunized mice.
    Buttinelli G; Ruggeri FM; Marturano J; Novello F; Donati V; Fiore L
    Virology; 2001 Mar; 281(2):265-71. PubMed ID: 11277698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of a monoclonal antibody and of DNA recombinant technology for the localization of a poliovirus neutralization epitope in viral capsid polypeptide VP1.
    Bruneau P; van der Werf S; Wychowski C; Siffert O; Girard M
    Dev Biol Stand; 1984; 57():177-85. PubMed ID: 6084609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens.
    Shahhosseini S; Das D; Qiu X; Feldmann H; Jones SM; Suresh MR
    J Virol Methods; 2007 Jul; 143(1):29-37. PubMed ID: 17368819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electron microscopic examination of the reactivity of three kinds of neutralizing antibodies with H particles of poliovirus.
    Taniguchi K; Urasawa S; Urasawa T
    Microbiol Immunol; 1983; 27(7):645-8. PubMed ID: 6195513
    [No Abstract]   [Full Text] [Related]  

  • 37. [A comparison of the diagnostic value of the virus neutralization reaction and of indirect immunoenzyme analysis using monoclonal antibodies for the intratype differentiation of vaccinal and virulent poliovirus strains].
    Nikolaienko IV
    Lik Sprava; 1998 May; (3):84-6. PubMed ID: 9695574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different virus-precipitating activities of neutralizing monoclonal antibodies that recognize distinct sites of poliovirus particles.
    Taniguchi K; Urasawa S
    Arch Virol; 1987; 92(1-2):27-40. PubMed ID: 2432854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Type-specific and strain-specific monoclonal antibody against type 1 poliovirus].
    Gu FZ
    Zhonghua Yi Xue Za Zhi; 1983 Feb; 63(2):69-72. PubMed ID: 6305464
    [No Abstract]   [Full Text] [Related]  

  • 40. Stabilization by host cell components and Mg2+ of the neutralization epitopes of poliovirus.
    Rombaut B; Vrijsen R; Boeyé A
    J Gen Virol; 1985 Feb; 66 ( Pt 2)():303-7. PubMed ID: 2578552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.